TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/7/24 19:44 | 11/5/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S.d | -3,395 | 35.00 | 0 | -97 | -16 | 505 | D | ||||||||||||||
11/1/24 18:43 | 10/30/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S | -36 | 31.40 | 0 | -1 | 0 | 505 | D | ||||||||||||||
8/14/24 19:12 | 8/12/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S | -565 | 27.06 | 0 | -21 | -4 | 506 | D | ||||||||||||||
8/9/24 19:32 | 8/7/24 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S.d | -2,375 | 25.00 | 0 | -95 | -15 | 527 | D | ||||||||||||||
9/1/23 20:15 | 8/30/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S | -103 | 22.47 | 0 | -5 | -1 | 406 | D | ||||||||||||||
3/1/23 19:56 | 2/27/23 | EXEL | Exelixis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Aftab Dana | CA | O | CSO,EVP | S.dm | -1,444 | 17.50 | 0 | -83 | -19 | 357 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |